Malignancy-related mir-210, mir-373 and let-7 levels are affected in iron deficiency anemia
- PMID: 38357103
- PMCID: PMC10862612
- DOI: 10.4314/ahs.v23i3.30
Malignancy-related mir-210, mir-373 and let-7 levels are affected in iron deficiency anemia
Abstract
Background: Hypoxia is the hallmark of iron deficiency anemia (IDA) and in hypoxic environment, significant changes are observed in malignancy-related microRNAs (miRNA). Our aim is to examine whether there is any difference in the levels of miR-210, miR-373 and let-7, which are directly related to malignancies in patients with IDA.
Methods: Thirty-five female patients with IDA between the ages of 18-65 and 10 healthy controls were included in the study. Patients who received oral iron therapy, who had inflammatory disease, and who were pregnant were excluded from the study. Student t Test was used for comparing variables with normal distribution in two independent groups, and Mann-Whitney U Test was used for variables without normal distribution. Comparison of categorical data was made using the chi-square test.
Results: The mean hemoglobin and ferritin level were 10,78±0,93 and 6.28±5,76 respectively. Plasma miR-210 expression were found as -7.27±2.23 and -6.15±0,88 in IDA and control group respectively (p = 0.022). Plasma miRNA-373 were -7.36±2,58 and -6,96±1,93 and let-7 expression were 2.14±2,15 and 3,57±2,21 in IDA and control group. (p = 0.65 and p = 0.20, respectively).
Conclusions: Plasma miR-210 expression was significantly up-regulated and miR-373 and let-7 expression was down-regulated, though insignificantly, in IDA group.
Keywords: iron deficiency anemia; malignancy; miRNA.
© 2023 Sak R et al.
Conflict of interest statement
The authors declare no conflict of interest for the study.
Figures
References
-
- Hung N, Shen CC, Hu YW, Hu LY, Yeh CM, Teng CJ, et al. Risk of cancer in patients with iron deficiency anemia: a nationwide population-based study. PLoS One. 2015 Mar 17;10(3):e0119647. Doi: 10.1371/journal.pone.0119647. Erratum in: PLoS One. 2015;10(4):e0125951. PMID: 25781632; PMCID: PMC4363660. - PMC - PubMed
-
- Joosten E. Iron deficiency anemia in older adults: A review. Geriatr Gerontol Int. 2018 Mar;18(3):373–379. Doi: 10.1111/ggi.13194. Epub 2017 Nov 2. PMID: 29094497. - PubMed
-
- Tymoszuk P, Nairz M, Brigo N, Petzer V, Heeke S, Kircher B, et al. Iron Supplementation Interferes with Immune Therapy of Murine Mammary Carcinoma by Inhibiting Anti-Tumor T Cell Function. Front Oncol. 2020 Dec 4;10:584477. Doi: 10.3389/fonc.2020.584477. PMID: 33344239; PMCID: PMC7746876. - PMC - PubMed
-
- Harrison IP, Selemidis S. Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets. Clin Exp Pharmacol Physiol. 2014 Aug;41(8):533–542. Doi: 10.1111/1440-1681.12238. PMID: 24738947. - PubMed
-
- Prá D, Franke SI, Henriques JA, Fenech M. Iron and genome stability: an update. Mutat Res. 2012 May 1;733(1-2):92–99. Doi: 10.1016/j.mrfmmm.2012.02.001. Epub 2012 Feb 13. PMID: 22349350. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources